Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for prevention of contrast-induced nephropathy
IRCT20210413050958N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in contrast-induced nephropathy (CIN), sponsored by Mashhad University of Medical Sciences. Started Apr 2022; status: completed.
02
Drugs
curcumin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT20210413050958N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210413050958N2.